skip to Main Content
Menu

Our Disctinct Advantage
20-for-20

20 Years Oncology Only

Unapparelled expertise in the field of oncology

… Above All

20 Years Canada Only

Singular focus on regional excellence

… Always

20 Years of Success

No rescue of a trial by another CRO

… Absolutely

20 Years Serving U.S. Drug Developers

We know how to meet our clients’ needs

… Without Exception

20 Years Collaborating with other CROs

We’re a flexible & nimble trial partner

… Always a good match

20 Year Focus on Matching Needs of all Stakeholders

Reverse Feasibility Program™

… Benefits the Whole

20 Years of Surpassing the North American Industry Average

… for Every Single Trial

20 Years of Oncology Team Member Expertise

CRAs with oncology experience and privileged Site relationships

… Every One of Them

20 Years of Oncology Trial Management

Phase 1-3 performance numbers that speak louder than words

… We ‘Walk Our Talk’

20 Years of Respect & Value for our team

Satisfied, dedicated, loyal engaged employees

… Working for Your Trial Success

20 Years of Operations Excellence

Seamless operational communications – no silos, no internal bottlenecks

… Best in Our Niche

20 Years Ensuring Site Satisfaction

Pioneers of the patient-centric model in Canada

Decades Ahead of the Competition

20 Years of Regulatory Submissions through Canadian Authorities

Keeping ahead of the changing landscape

… Timely & Effective

20 Years Solid Patient Recruitment Results

Quick start-up and high patient recruitment

… Contributes to Your Trials Overall Success

20 Years of Satisfied Sponsor Referrals

We’re proud of our repeat business

… Because we Surpass Expectations

20 Years of Steady, Dedicated Executive Leadership

Co-founders are passionate and involved

… Your Trials Matters

20 Years Managing Risk & Solving Problems

We’re diligent and trained to think outside-the-box

… Put Our Know-How to Work for Your Trial

20 Years of Growth

Due to dedication and excellence in the Canadian oncology research niche

… Distinct & Not to be Overlooked

20 Years Protecting Patient Security & Well Being

At the very heart of why we do what we do

… to Better Serve You

20 Years of Meaningful Contributions

a Track Record We’re Proud of

Our Mission

We are a Canadian oncology CRO with a singular focus on oncology. We play a vital role in improving the speed and efficiency of oncology clinical research through a deep understanding of the needs of sponsors, investigators and patients.

Our mission is to improve site selection and patient recruitment, and speed up clinical trials by attracting cutting-edge oncology compounds and clinical trials to Canada. The Reverse Feasibility Program is designed to connect small and mid-sized biopharma companies with a network of highly motivated investigators and their patients.

We believe that the rise of targeted therapies and personalized medicine should not increase operational complexity or compromise the efficiency of clinical trials.

Our Story

Scimega was founded to meet the industry’s need for superior clinical trial services in the complex field of oncology research. In 1997, we were trail blazers, and most sponsors didn’t understand the importance of our unique business model. Since then many have come to value our expertise.

In 2008, we introduced the Reverse Feasibility Program – a collaborative approach that connects biotech sponsors with investigators to meet the needs of cancer patients, and the scientific interests of investigators while allowing sponsors to meet their timelines and make quicker go/no-go drug development decisions.

With 20 years of dedicated oncology experience under our belts, our service offering is now finely tuned at a time when our clients need us most.

Our Leadership

We are passionate advocates of the clinical oncology research community and take great pride in our team’s ongoing success in helping sponsors enhance the speed, accuracy and overall performance of their early phase oncology clinical trials.

We are also proud of the vital role we play in helping to build and maintain strong relationships between sponsors and investigative sites, in pursuit of cutting-edge clinical research that serves to enhance the quality of life of people living with cancer.

Denise Deakin
President & Co-Founder

Andree Marceau
General Manager & Co-Founder

Nathan Currier, PhD
Director, Oncology Strategy & Alliances

Julie Martin, MSc, MBA
Director, Clinical Operations

Catherine Ménard, MSc
Director, Quality and Human Resources

Geneviève Piché
Director, Finance

Back To Top
Close search
Search